Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)
Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of ...
U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application
Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...
Theratechnologies Provides Update on EGRIFTA SV® Supply
“We remain committed to people with HIV who rely on EGRIFTA SV®, as it is the only FDA-approved medicine of its kind, and we will continue to work with the FDA to expedite the release of the new ...
PMDD treatment: Doctors share remedies that may help symptoms
PMDD or premenstrual dysphoric disorder causes mood swings and other severe symptoms. Doctors discuss what it is and possible ...
Bioengineered Blood Vessels Show Promise in Trauma Care
First human trials at Rutgers Health and other institutions demonstrate better infection resistance and limb preservation ...
Chinese Cat Owners Are Feeding Covid-19 Pills To Their Pets. Here's Why
Merck & Co.'s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as ...
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...
Florida was to expand children’s health insurance. Instead, it’s been kicking kids off its rolls
A Florida law that was to start January 1 would give them better coverage at a much lower rate, but the state has delayed implementing it.
ONWARD Medical Announces First Commercial Sales Of ARC-EX System
ARC-EX was named a 2024 TIME Magazine Best Invention ...
Assembly Mag2d
New Adhesives and Dispensing Technology
Adhesives can do more than just bond two parts together. They can conduct electric current—or insulate current. They can ...
ots3d
Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in
Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the ...
Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives
Citius Oncology, Inc. ("Citius Oncology" or "the Company") (Nasdaq: CTOR), a majority-owned subsidiary of Citius ...